Cost-minimization Analysis of Prostaglandins Drugs in the Treatment of Glaucoma
10.6039/j.issn.1001-0408.2015.35.01
- VernacularTitle:前列腺素类药物治疗青光眼的最小成本分析
- Author:
Yue HU
;
Ziqi LIU
;
Chunyu ZHANG
;
Manling MA
- Publication Type:Journal Article
- Keywords:
Prostaglandins drugs;
Bimatoprost;
Latanoprost;
Travoprost;
Glaucoma;
Economics;
Cost-minimization analysis
- From:
China Pharmacy
2015;26(35):4897-4899
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the curative effect and economics of prostaglandins drugs in the treatment of glauco-ma,and to provide reference for clinical medication. METHODS:In retrospective study,a total of 790 glaucoma patients were di-vided into latanoprost group(62 cases),travoprost group(356 cases)and bimatoprost group(372 cases)according to therapy regi-men. They were given relevant medicine. Total effective rate of 3 groups were calculated,and the cost-minimization method was used for pharmacoeconomics evaluation. RESULTS:The total effective rate of 3 groups were 87.10%,84.27%,76.08% respective-ly,without statistical significance(P>0.05). The cost of them were 208.00 yuan,225.00 yuan and 173.00 yuan,and that of bima-toprost group was the lowest. The results of sensitivity analysis was in line with that of cost-minimization analysis. CONCLU-SIONS:For glaucoma,bimatoprost is more economical than latanoprost and travoprost.
